Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Endovascular Intervention for Aneurysmal SAH
NCT06352593Completed
- Sponsor
- Tanta University
- Start
- Apr 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in aneurysmal subarachnoid hemorrhage (SAH) comparing Group D (Dexmedetomidine) with Group C (Placebo) (2 arms). Primary endpoint: Incidence of vasospasm at 14 days. Started Apr 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT06352593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06352593.